Clinical Trial Update: Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active Drugs [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating weight loss and body composition changes after dosing with placebo or two active drugs in adults with Type 2 diabetes mellitus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2, Obesity | Phase 1 | Status: COMPLETED